share_log

EFFECT: Others

EFFECT: Others

EFFECT：其他
美股SEC公告 ·  09/17 18:05
牛牛AI助理已提取核心訊息
Conduit Pharmaceuticals, known in the stock market as CDT.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC). On September 10, 2024, at 5:00 P.M., the SEC granted effectiveness to the company's Form F-1 filing. This development is a critical step for Conduit Pharmaceuticals, which operates under the legal name Genius Group Ltd, as indicated by its CIK number 0001847806. The effectiveness of the Form F-1, associated with file number 333-279795, marks a pivotal moment for the company's future financial activities.
Conduit Pharmaceuticals, known in the stock market as CDT.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC). On September 10, 2024, at 5:00 P.M., the SEC granted effectiveness to the company's Form F-1 filing. This development is a critical step for Conduit Pharmaceuticals, which operates under the legal name Genius Group Ltd, as indicated by its CIK number 0001847806. The effectiveness of the Form F-1, associated with file number 333-279795, marks a pivotal moment for the company's future financial activities.
Conduit Pharmaceuticals，在股票市場上被稱爲CDt.US，在2024年9月10日下午5:00，美國證券交易委員會（SEC）授予了公司的F-1表格效力。這一發展對Conduit Pharmaceuticals來說是一個關鍵的步驟，該公司在法律名稱上運營爲Genius Group Ltd，其CIK編號爲0001847806。與文件號333-279795相關的F-1表格的有效性標誌着公司未來財務活動的轉折時刻。
Conduit Pharmaceuticals，在股票市場上被稱爲CDt.US，在2024年9月10日下午5:00，美國證券交易委員會（SEC）授予了公司的F-1表格效力。這一發展對Conduit Pharmaceuticals來說是一個關鍵的步驟，該公司在法律名稱上運營爲Genius Group Ltd，其CIK編號爲0001847806。與文件號333-279795相關的F-1表格的有效性標誌着公司未來財務活動的轉折時刻。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。